Efficacy and safety of CDK 4/6 inhibitors in patients with bone marrow-involved metastatic breast cancer

Basit Öğe Kaydı
dc.authoridkahraman, seda/0000-0002-5328-6554
dc.authoridMUTLU, EMEL/0000-0002-1008-2527
dc.contributor.authorKaracin, C.
dc.contributor.authorAslan, F.
dc.contributor.authorDumludag, A.
dc.contributor.authorAlkan, A.
dc.contributor.authorTurker, M.
dc.contributor.authorYucel, K. Bir
dc.contributor.authorMutlu, E.
dc.date.accessioned2024-10-29T17:58:15Z
dc.date.available2024-10-29T17:58:15Z
dc.date.issued2023
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.descriptionCongress of the European-Society-for-Medical-Oncology (ESMO) -- OCT 20-24, 2023 -- Madrid, SPAIN
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean Soc Med Oncol
dc.identifier.doi10.1016/j.annonc.2023.09.619
dc.identifier.endpageS368
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpageS368
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2023.09.619
dc.identifier.urihttps://hdl.handle.net/20.500.11776/14160
dc.identifier.volume34
dc.identifier.wosWOS:001087480200431
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEfficacy and safety of CDK 4/6 inhibitors in patients with bone marrow-involved metastatic breast cancer
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu